Juliette Berangere Audet Insider Profile
4 Followers
Juliette Berangere Audet, Chief Strategy and Business Officer at NewAmsterdam Pharma Company, holds 15.10K shares in NewAmsterdam Pharma Company (Ticker: NAMS).
Juliette Berangere Audet NewAmsterdam Pharma Company (NAMS)Chief Strategy and Business Officer
NewAmsterdam Pharma Company (NAMS)
Chief Strategy and Business Officer
Not Ranked
Juliette Berangere Audet has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Juliette Berangere Audet's holdings
Insider Roles
Chief Strategy and Business Officer
Roles that Juliette Berangere Audet holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Juliette Berangere Audet
Juliette Berangere Audet's Trading History
List of latest transactions for each holding click on a transaction to see Juliette Berangere Audet's performance on stock
You May Also Like
Juliette Berangere Audet insider profile FAQ
What is the percentage of profitable transactions made by Juliette Berangere Audet?
The percentage of profitable transactions made by Juliette Berangere Audet is ―.
What is the average return per transaction made by Juliette Berangere Audet?
The average return per transaction made by Juliette Berangere Audet is ―.
What stocks does Juliette Berangere Audet hold?
Juliette Berangere Audet holds: NAMS stocks.
What was Juliette Berangere Audet’s latest transaction?
Juliette Berangere Audet latest transaction was an Uninformative Buy of ―.
What was Juliette Berangere Audet's most profitable transaction?
Juliette Berangere Audet’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Juliette Berangere Audet's role in NewAmsterdam Pharma Company?
Juliette Berangere Audet's role in NewAmsterdam Pharma Company is Chief Strategy and Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.